These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35789154)

  • 1. Myotonic dystrophy RNA toxicity alters morphology, adhesion and migration of mouse and human astrocytes.
    Dincã DM; Lallemant L; González-Barriga A; Cresto N; Braz SO; Sicot G; Pillet LE; Polvèche H; Magneron P; Huguet-Lachon A; Benyamine H; Azotla-Vilchis CN; Agonizantes-Juárez LE; Tahraoui-Bories J; Martinat C; Hernández-Hernández O; Auboeuf D; Rouach N; Bourgeois CF; Gourdon G; Gomes-Pereira M
    Nat Commun; 2022 Jul; 13(1):3841. PubMed ID: 35789154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative Cell Type-Specific Multi-Omics Approaches Reveal Impaired Programs of Glial Cell Differentiation in Mouse Culture Models of DM1.
    González-Barriga A; Lallemant L; Dincã DM; Braz SO; Polvèche H; Magneron P; Pionneau C; Huguet-Lachon A; Claude JB; Chhuon C; Guerrera IC; Bourgeois CF; Auboeuf D; Gourdon G; Gomes-Pereira M
    Front Cell Neurosci; 2021; 15():662035. PubMed ID: 34025359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of the Glial GLT1 Glutamate Transporter and Purkinje Cell Dysfunction in a Mouse Model of Myotonic Dystrophy.
    Sicot G; Servais L; Dinca DM; Leroy A; Prigogine C; Medja F; Braz SO; Huguet-Lachon A; Chhuon C; Nicole A; Gueriba N; Oliveira R; Dan B; Furling D; Swanson MS; Guerrera IC; Cheron G; Gourdon G; Gomes-Pereira M
    Cell Rep; 2017 Jun; 19(13):2718-2729. PubMed ID: 28658620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synaptic protein dysregulation in myotonic dystrophy type 1: Disease neuropathogenesis beyond missplicing.
    Hernández-Hernández O; Sicot G; Dinca DM; Huguet A; Nicole A; Buée L; Munnich A; Sergeant N; Gourdon G; Gomes-Pereira M
    Rare Dis; 2013; 1():e25553. PubMed ID: 25003003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age of onset of RNA toxicity influences phenotypic severity: evidence from an inducible mouse model of myotonic dystrophy (DM1).
    Gladman JT; Mandal M; Srinivasan V; Mahadevan MS
    PLoS One; 2013; 8(9):e72907. PubMed ID: 24039817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myotonic dystrophy CTG expansion affects synaptic vesicle proteins, neurotransmission and mouse behaviour.
    Hernández-Hernández O; Guiraud-Dogan C; Sicot G; Huguet A; Luilier S; Steidl E; Saenger S; Marciniak E; Obriot H; Chevarin C; Nicole A; Revillod L; Charizanis K; Lee KY; Suzuki Y; Kimura T; Matsuura T; Cisneros B; Swanson MS; Trovero F; Buisson B; Bizot JC; Hamon M; Humez S; Bassez G; Metzger F; Buée L; Munnich A; Sergeant N; Gourdon G; Gomes-Pereira M
    Brain; 2013 Mar; 136(Pt 3):957-70. PubMed ID: 23404338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HNRNPA1-induced spliceopathy in a transgenic mouse model of myotonic dystrophy.
    Li M; Zhuang Y; Batra R; Thomas JD; Li M; Nutter CA; Scotti MM; Carter HA; Wang ZJ; Huang XS; Pu CQ; Swanson MS; Xie W
    Proc Natl Acad Sci U S A; 2020 Mar; 117(10):5472-5477. PubMed ID: 32086392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic exercise mitigates disease mechanisms and improves muscle function in myotonic dystrophy type 1 mice.
    Manta A; Stouth DW; Xhuti D; Chi L; Rebalka IA; Kalmar JM; Hawke TJ; Ljubicic V
    J Physiol; 2019 Mar; 597(5):1361-1381. PubMed ID: 30628727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DM1 Transgenic Mice Exhibit Abnormal Neurotransmitter Homeostasis and Synaptic Plasticity in Association with RNA Foci and Mis-Splicing in the Hippocampus.
    Potier B; Lallemant L; Parrot S; Huguet-Lachon A; Gourdon G; Dutar P; Gomes-Pereira M
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sense and Antisense DMPK RNA Foci Accumulate in DM1 Tissues during Development.
    Michel L; Huguet-Lachon A; Gourdon G
    PLoS One; 2015; 10(9):e0137620. PubMed ID: 26339785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bruno-3 regulates sarcomere component expression and contributes to muscle phenotypes of myotonic dystrophy type 1.
    Picchio L; Legagneux V; Deschamps S; Renaud Y; Chauveau S; Paillard L; Jagla K
    Dis Model Mech; 2018 May; 11(5):. PubMed ID: 29716962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart-specific overexpression of CUGBP1 reproduces functional and molecular abnormalities of myotonic dystrophy type 1.
    Koshelev M; Sarma S; Price RE; Wehrens XH; Cooper TA
    Hum Mol Genet; 2010 Mar; 19(6):1066-75. PubMed ID: 20051426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribonuclear foci at the neuromuscular junction in myotonic dystrophy type 1.
    Wheeler TM; Krym MC; Thornton CA
    Neuromuscul Disord; 2007 Mar; 17(3):242-7. PubMed ID: 17306536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of RNA toxicity in myotonic dystrophy via a decoy RNA-binding protein with high affinity for expanded CUG repeats.
    Arandel L; Matloka M; Klein AF; Rau F; Sureau A; Ney M; Cordier A; Kondili M; Polay-Espinoza M; Naouar N; Ferry A; Lemaitre M; Begard S; Colin M; Lamarre C; Tran H; Buée L; Marie J; Sergeant N; Furling D
    Nat Biomed Eng; 2022 Feb; 6(2):207-220. PubMed ID: 35145256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Furamidine Rescues Myotonic Dystrophy Type I Associated Mis-Splicing through Multiple Mechanisms.
    Jenquin JR; Coonrod LA; Silverglate QA; Pellitier NA; Hale MA; Xia G; Nakamori M; Berglund JA
    ACS Chem Biol; 2018 Sep; 13(9):2708-2718. PubMed ID: 30118588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation.
    Kuyumcu-Martinez NM; Wang GS; Cooper TA
    Mol Cell; 2007 Oct; 28(1):68-78. PubMed ID: 17936705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A CTG repeat-selective chemical screen identifies microtubule inhibitors as selective modulators of toxic CUG RNA levels.
    Reddy K; Jenquin JR; McConnell OL; Cleary JD; Richardson JI; Pinto BS; Haerle MC; Delgado E; Planco L; Nakamori M; Wang ET; Berglund JA
    Proc Natl Acad Sci U S A; 2019 Oct; 116(42):20991-21000. PubMed ID: 31570586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoplasmic CUG RNA foci are insufficient to elicit key DM1 features.
    Dansithong W; Wolf CM; Sarkar P; Paul S; Chiang A; Holt I; Morris GE; Branco D; Sherwood MC; Comai L; Berul CI; Reddy S
    PLoS One; 2008; 3(12):e3968. PubMed ID: 19092997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RAN Translation Regulated by Muscleblind Proteins in Myotonic Dystrophy Type 2.
    Zu T; Cleary JD; Liu Y; Bañez-Coronel M; Bubenik JL; Ayhan F; Ashizawa T; Xia G; Clark HB; Yachnis AT; Swanson MS; Ranum LPW
    Neuron; 2017 Sep; 95(6):1292-1305.e5. PubMed ID: 28910618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myotonic dystrophy: is a narrow focus obscuring the rest of the field?
    Mahadevan MS
    Curr Opin Neurol; 2012 Oct; 25(5):609-13. PubMed ID: 22892953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.